Sarah James
Stock Analyst at Cantor Fitzgerald
(1.86)
# 3,129
Out of 4,935 analysts
284
Total ratings
30.09%
Success rate
-8.13%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Maintains: Overweight | $26 → $28 | $22.85 | +22.54% | 15 | Aug 8, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $9 → $4 | $2.83 | +41.34% | 7 | Aug 8, 2025 | |
| CNC Centene | Downgrades: Neutral | $65 → $38 | $25.59 | +48.50% | 14 | Jul 28, 2025 | |
| MOH Molina Healthcare | Downgrades: Neutral | $312 → $210 | $156.90 | +33.84% | 12 | Jul 25, 2025 | |
| HUM Humana | Reiterates: Neutral | $290 | $266.68 | +8.74% | 21 | May 1, 2025 | |
| ELV Elevance Health | Reiterates: Overweight | $485 | $293.99 | +64.97% | 20 | Apr 23, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $350 → $365 | $274.90 | +32.78% | 21 | Mar 20, 2025 | |
| TBRG TruBridge | Maintains: Overweight | $20 → $29 | $18.91 | +53.36% | 6 | Mar 11, 2025 | |
| LFMD LifeMD | Reiterates: Overweight | $15 | $6.82 | +119.94% | 11 | Mar 11, 2025 | |
| THC Tenet Healthcare | Reiterates: Overweight | $177 | $165.58 | +6.90% | 20 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $405 | $381.61 | +6.13% | 19 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $700 | $250.89 | +179.01% | 17 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $52 | $19.24 | +170.27% | 13 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $219 | $172.30 | +27.10% | 24 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $23.67 | +81.66% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $62 | $65.54 | -5.40% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $1.57 | +218.47% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $6.96 | +43.68% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $100.94 | +0.06% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $129.50 | +2.70% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $24.60 | +70.73% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $3.31 | +51.06% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $6.14 | -18.57% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $14.51 | +44.73% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $53.36 | -26.91% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $65.94 | +192.69% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.49 | - | 2 | Mar 1, 2017 |
Progyny
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $22.85
Upside: +22.54%
Health Catalyst
Aug 8, 2025
Downgrades: Neutral
Price Target: $9 → $4
Current: $2.83
Upside: +41.34%
Centene
Jul 28, 2025
Downgrades: Neutral
Price Target: $65 → $38
Current: $25.59
Upside: +48.50%
Molina Healthcare
Jul 25, 2025
Downgrades: Neutral
Price Target: $312 → $210
Current: $156.90
Upside: +33.84%
Humana
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $266.68
Upside: +8.74%
Elevance Health
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $293.99
Upside: +64.97%
The Cigna Group
Mar 20, 2025
Maintains: Overweight
Price Target: $350 → $365
Current: $274.90
Upside: +32.78%
TruBridge
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $18.91
Upside: +53.36%
LifeMD
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $6.82
Upside: +119.94%
Tenet Healthcare
Feb 13, 2025
Reiterates: Overweight
Price Target: $177
Current: $165.58
Upside: +6.90%
Jan 27, 2025
Reiterates: Overweight
Price Target: $405
Current: $381.61
Upside: +6.13%
Jan 17, 2025
Reiterates: Overweight
Price Target: $700
Current: $250.89
Upside: +179.01%
Dec 10, 2024
Reiterates: Neutral
Price Target: $52
Current: $19.24
Upside: +170.27%
Oct 25, 2024
Reiterates: Neutral
Price Target: $219
Current: $172.30
Upside: +27.10%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $23.67
Upside: +81.66%
Oct 1, 2024
Reiterates: Neutral
Price Target: $62
Current: $65.54
Upside: -5.40%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $1.57
Upside: +218.47%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $6.96
Upside: +43.68%
Jul 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $100.94
Upside: +0.06%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $129.50
Upside: +2.70%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $24.60
Upside: +70.73%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $3.31
Upside: +51.06%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $6.14
Upside: -18.57%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $14.51
Upside: +44.73%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $53.36
Upside: -26.91%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $65.94
Upside: +192.69%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $2.49
Upside: -